These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2979221)

  • 1. Review: post-marketing surveillance of the safety of cimetidine--the problems of data interpretation.
    Jones DG; Langman MJ; Lawson DH; Vessey MP
    Aliment Pharmacol Ther; 1987 Jun; 1(3):167-77. PubMed ID: 2979221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report.
    Colin Jones DG; Langman MJ; Lawson DH; Vessey MP
    Q J Med; 1985 Mar; 54(215):253-68. PubMed ID: 3991880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug surveillance. Monitoring the side-effects of drugs in the post-marketing phase: cimetidine. II].
    Mariani L; Minora T
    Clin Ter; 1984 Apr; 109(2):109-25. PubMed ID: 6234121
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.
    Colin-Jones DG; Langman MJ; Lawson DH; Vessey MP
    Br Med J (Clin Res Ed); 1983 May; 286(6379):1713-6. PubMed ID: 6405946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of record linkage in post-marketing drug surveillance.
    Crombie IK
    Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):77S-82S. PubMed ID: 3567036
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of age with the efficacy and safety of ranitidine and cimetidine in acute duodenal ulcer disease.
    Dixon JS; Mills JG; Ehsanullah RS; Wood JR
    Age Ageing; 1993 Nov; 22(6):411-8. PubMed ID: 8310886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.
    Colin-Jones DG; Langman MJ; Lawson DH; Vessey MP
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1311-3. PubMed ID: 6812688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug surveillance. Monitoring the collateral effects of drugs in the post-marketing phase: cimetidine. I].
    Mariani L; Minora T
    Clin Ter; 1984 Apr; 109(1):3-17. PubMed ID: 6233077
    [No Abstract]   [Full Text] [Related]  

  • 9. A unique postmarket outpatient surveillance program of cimetidine: report on phase II and final summary.
    Humphries TJ; Myerson RM; Gifford LM; Aeugle ME; Josie ME; Wood SL; Tannenbaum PJ
    Am J Gastroenterol; 1984 Aug; 79(8):593-6. PubMed ID: 6465106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing surveillance of the safety of cimetidine.
    Crombie IK
    Br Med J (Clin Res Ed); 1983 Jun; 286(6383):2062. PubMed ID: 6409227
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmarketing surveillance of the safety of cimetidine: 10 year mortality report.
    Colin-Jones DG; Langman MJ; Lawson DH; Logan RF; Paterson KR; Vessey MP
    Gut; 1992 Sep; 33(9):1280-4. PubMed ID: 1358768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.
    Colin-Jones DG; Langman MJ; Lawson DH; Vessey MP
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1084-8. PubMed ID: 3931805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine postmarket outpatient surveillance program. Interim report on phase I.
    Gifford LM; Aeugle ME; Myerson RM; Tannenbaum PJ
    JAMA; 1980 Apr; 243(15):1532-5. PubMed ID: 7359735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression not associated with cimetidine.
    Antell LA; Murabito AS; Karlstadt RG
    Pa Med; 1989 Nov; 92(11):26, 28. PubMed ID: 2636871
    [No Abstract]   [Full Text] [Related]  

  • 15. Antisecretory drugs. Safe and effective?
    Langman MJ
    Drugs; 1988; 35 Suppl 3():17-9. PubMed ID: 2905244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus.
    Colin-Jones DG; Langman MJ; Lawson DH; Logan RF; Paterson KR; Vessey MP
    Q J Med; 1991 Jan; 78(285):13-9. PubMed ID: 1670060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients.
    Hall M; Monka C; Krupp P; O'Sullivan D
    Arch Dermatol; 1997 Oct; 133(10):1213-9. PubMed ID: 9382559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years.
    Walan A; Bianchi-Porro G; Hentschel E; Bardhan KD; Delattre M
    Scand J Gastroenterol; 1987 May; 22(4):397-405. PubMed ID: 3299677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Anglo-Irish Cimetidine Long-Term Study Group.
    Bardhan KD
    Aliment Pharmacol Ther; 1988 Oct; 2(5):395-405. PubMed ID: 2979263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug safety data mining with a tree-based scan statistic.
    Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):517-23. PubMed ID: 23512870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.